Each year, influenza viruses cause up to 650,000 deaths. To aid in the development of a universal influenza virus vaccine that would save more lives, authors of a new study sought to identify alternative...
The FDA has approved the first vaccine approved in the US for the prevention of dengue disease caused by all 4 serotypes of dengue virus in patients aged 9 through 16 years with laboratory-confirmed...
After 2 randomized clinical trials found it as safe and effective as the standard 3-drug regimen, the FDA approved the first 2-drug regimen for adults with HIV-1 who have never been treated with ART.
According to WHO, an influenza pandemic is inevitable. What will be key in how it will affect the world’s population is how prepared the health care industry is for it. The new Global Influenza Strategy...
With the aging HIV population, it is important to understand how inflammation and age-related comorbidities will affect treatment options in this population moving forward. This was the topic of Tuesday’s...
With the aging HIV population, it is important to understand how inflammation and age-related comorbidities will affect treatment options in this population moving forward. This was the topic of Tuesday’s...
Results of a new study presented at CROI 2019, found the efficacy and safety of F/TAF versus F/TDF for PrEP in MSM and transgender women who are at high risk of HIV acquisition.
Results of a new study presented at CROI 2019, found the efficacy and safety of F/TAF versus F/TDF for PrEP in MSM and transgender women who are at high risk of HIV acquisition.
In this plenary session, Alexandra M. Oster, from the CDC, discusses molecular detection of HIV clusters, how the United States has used that data, and how researchers have responded to these clusters. ...
